BIOTRONIK Neuro will unveil new data from the BENEFIT-03 clinical study at the North American Neuromodulation Society (NANS) 2025 Annual Meeting. The findings highlight the transformative potential of ...

In a report released today, Emily Field from Barclays maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a price target ...

Resbiotic Nutrition Inc. ("resbiotic" or "res"), a leading provider of physician-formulated and science-backed dietary supplements, has announced a strategic distribution agreement with Grupo Columbia ...

Adoption of Triple Combination Therapy Accelerates at Unprecedented Rates as Precision Medicine Revolution ContinuesRockville, MD, Jan. 29, 2025 (GLOBE NEWSWIRE) -- According to Fact.MR, a market ...

Co-branded advertising—where brands collaborate with movies for promotional tie-ups—continued to grow in 2024, with over 60 ...

Three recent big-ticket M&A deals have raised expectations the global biotech sector is recovering from its two-year slump.

Jefferies analyst Peter Welford maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £14.50. The ...

The prescribing information for two respiratory syncytial virus (RSV) vaccines will now include a warning for the increased ...

Jumoke Oduwole, Nigeria’s minister of industry, trade and investment outlines her strategy to attract foreign direct investment and support businesses in a tough economic climate.

UnitedHealth reported fourth-quarter results on Thursday that reflected persistent challenges for the health insurance sector ...

Tempus AI is projected to achieve 30% YoY top line growth in Q4 2024 as presented in its preliminary results. Click here to ...

World’s First “Universal” Robotics Software Platform BOW Raises £4 Million Seed to Reduce Cost and Complexity of Programming ...